Weekly review: Dupilumab, lebrikizumab FDA approved, plus much more – Contemporary Pediatrics September 21, 2024 Medicine Weekly review: Dupilumab, lebrikizumab FDA approved, plus much more Contemporary Pediatrics Regeneron, SNY Win FDA Approval for a Broader Dupixent Label Yahoo Finance First Drug OK’d for Chronic Rhinosinusitis With Nasal Polyps in Adolescents Medpage Today FDA Approves Dupilumab Label Expansion… Source link
September 21, 2024 Medicine Weekly review: Dupilumab, lebrikizumab FDA approved, plus much more Contemporary Pediatrics Regeneron, SNY Win FDA Approval for a Broader Dupixent Label Yahoo Finance First Drug OK’d for Chronic Rhinosinusitis With Nasal Polyps in Adolescents Medpage Today FDA Approves Dupilumab Label Expansion… Source link